Akero Therapeutics, Inc.
US ˙ NasdaqGS ˙ US00973Y1082
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityAKRO / Akero Therapeutics, Inc.
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Citadel Advisors Llc ownership in AKRO / Akero Therapeutics, Inc.

On February 17, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 0 shares of Akero Therapeutics, Inc. (US:AKRO) valued at $0 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 685,842 shares of Akero Therapeutics, Inc.. The current value of the position is $0 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (AKRO) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

AKRO / Akero Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM 00973Y108 0 -100.00 0
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM 00973Y108 685,842 -483,840 -41.37 32,564 -47.83 0.0050
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM 00973Y108 1,169,682 -739,648 -38.74 62,414 -19.25 0.0108
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM 00973Y108 1,909,330 554,437 40.92 77,290 105.05 0.0147
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM 00973Y108 1,354,893 1,204,992 803.86 37,693 776.58 0.0065
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM 00973Y108 149,901 -245,216 -62.06 4,301 -53.61 0.0008
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM 00973Y108 395,117 -24,543 -5.85 9,269 -12.56 0.0019
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM 00973Y108 419,660 -65,365 -13.48 10,601 -6.40 0.0020
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM 00973Y108 485,025 182,438 60.29 11,325 -26.00 0.0023
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM 00973Y108 302,587 -23,305 -7.15 15,305 0.58 0.0033
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM 00973Y108 325,892 -529,816 -61.92 15,216 -53.53 0.0031
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM 00973Y108 855,708 593,991 226.96 32,739 128.27 0.0072
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM 00973Y108 261,717 84,556 47.73 14,342 137.77 0.0034
2022-11-14 2022-09-30 13F AKERO THERAPEUTICS COM 00973Y108 177,161 78,551 79.66 6,032 547.21 0.0014
2022-08-15 2022-06-30 13F AKERO THERAPEUTICS COM 00973Y108 98,610 10,800 12.30 932 -25.20 0.0002
2022-05-16 2022-03-31 13F AKERO THERAPEUTICS COM 00973Y108 87,810 60,371 220.02 1,246 114.83 0.0003
2022-02-14 2021-12-31 13F AKERO THERAPEUTICS COM 00973Y108 27,439 -5,430 -16.52 580 -21.09 0.0001
2021-11-15 2021-09-30 13F AKERO THERAPEUTICS Cmn 00973Y108 32,869 -25,193 -43.39 735 -48.96 0.0002
2021-08-16 2021-06-30 13F AKERO THERAPEUTICS COM 00973Y108 58,062 -82,813 -58.78 1,440 -64.77 0.0003
2021-05-21 2021-03-31 13F/A-1 AKERO THERAPEUTICS COM 00973Y108 140,875 -74,829 -34.69 4,087 -26.56 0.0010
2021-05-17 2021-03-31 13F AKERO THERAPEUTICS COM 00973Y108 140,875 -74,829 4,087 0.0010
2021-02-16 2020-12-31 13F AKERO THERAPEUTICS COM 00973Y108 215,704 175,013 430.10 5,565 344.13 0.0014
2020-11-16 2020-09-30 13F AKERO THERAPEUTICS COM 00973Y108 40,691 -16,924 -29.37 1,253 -12.74 0.0004
2020-08-14 2020-06-30 13F AKERO THERAPEUTICS Cmn 00973Y108 57,615 57,615 1,436 0.0005
2020-05-15 2020-03-31 13F AKERO THERAPEUTICS Cmn 00973Y108 0 -20,702 -100.00 0 -100.00
2020-02-14 2019-12-31 13F AKERO THERAPEUTICS Cmn 00973Y108 20,702 -2,517 -10.84 459 -13.07 0.0002
2019-11-14 2019-09-30 13F AKERO THERAPEUTICS Cmn 00973Y108 23,219 23,219 528 0.0002
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM Call 41,900 -43.61 1,989 -49.82 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Call 74,300 614.42 3,965 843.81 n/a n/a n/a
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM Call 10,400 -34.18 421 -4.33 n/a n/a n/a
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM Call 15,800 -61.65 440 -62.86 n/a n/a n/a
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM Call 41,200 -28.72 1,182 -12.77 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Call 57,800 -25.13 1,356 -30.51 n/a n/a n/a
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM Call 77,200 -21.86 1,950 -15.44 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Call 98,800 176.75 2,307 27.76 n/a n/a n/a
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM Call 35,700 39.45 1,806 51.05 n/a n/a n/a
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM Call 25,600 -51.61 1,195 -40.93 n/a n/a n/a
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM Call 52,900 -57.13 2,024 -70.08 n/a n/a n/a
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM Call 123,400 72.11 6,762 177.02 n/a n/a n/a
2022-11-14 2022-09-30 13F AKERO THERAPEUTICS COM Call 71,700 2,441 n/a n/a n/a
2021-08-16 2021-06-30 13F AKERO THERAPEUTICS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AKERO THERAPEUTICS COM Call 13,400 389 n/a n/a n/a
2021-05-17 2021-03-31 13F AKERO THERAPEUTICS COM Call 13,400 389 n/a n/a n/a
2020-08-14 2020-06-30 13F AKERO THERAPEUTICS Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-05-15 2020-03-31 13F AKERO THERAPEUTICS Cmn Call 14,000 297 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-02-17 2025-12-31 13F AKERO THERAPEUTICS COM Put 0 -100.00 0 n/a n/a n/a
2025-11-14 2025-09-30 13F AKERO THERAPEUTICS COM Put 55,700 -53.35 2,645 -58.50 n/a n/a n/a
2025-08-14 2025-06-30 13F AKERO THERAPEUTICS COM Put 119,400 67.23 6,371 120.45 n/a n/a n/a
2025-05-15 2025-03-31 13F AKERO THERAPEUTICS COM Put 71,400 244.93 2,890 402.61 n/a n/a n/a
2025-02-14 2024-12-31 13F AKERO THERAPEUTICS COM Put 20,700 -30.54 576 -32.67 n/a n/a n/a
2024-11-14 2024-09-30 13F AKERO THERAPEUTICS COM Put 29,800 -36.60 855 -22.50 n/a n/a n/a
2024-08-14 2024-06-30 13F AKERO THERAPEUTICS COM Put 47,000 -33.33 1,103 -38.09 n/a n/a n/a
2024-05-15 2024-03-31 13F AKERO THERAPEUTICS COM Put 70,500 29.83 1,781 40.49 n/a n/a n/a
2024-02-14 2023-12-31 13F AKERO THERAPEUTICS COM Put 54,300 6.47 1,268 -50.87 n/a n/a n/a
2023-11-14 2023-09-30 13F AKERO THERAPEUTICS COM Put 51,000 109.02 2,580 126.43 n/a n/a n/a
2023-08-14 2023-06-30 13F AKERO THERAPEUTICS COM Put 24,400 -0.41 1,139 21.56 n/a n/a n/a
2023-05-15 2023-03-31 13F AKERO THERAPEUTICS COM Put 24,500 -48.42 937 -64.00 n/a n/a n/a
2023-02-14 2022-12-31 13F AKERO THERAPEUTICS COM Put 47,500 -60.58 2,603 -36.56 n/a n/a n/a
2022-11-14 2022-09-30 13F AKERO THERAPEUTICS COM Put 120,500 4,103 n/a n/a n/a
2022-02-14 2021-12-31 13F AKERO THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-11-15 2021-09-30 13F AKERO THERAPEUTICS Cmn Put 14,400 -39.50 322 -45.42 n/a n/a n/a
2021-08-16 2021-06-30 13F AKERO THERAPEUTICS COM Put 23,800 -50.72 590 -57.89 n/a n/a n/a
2021-05-21 2021-03-31 13F/A AKERO THERAPEUTICS COM Put 48,300 397.94 1,401 460.40 n/a n/a n/a
2021-05-17 2021-03-31 13F AKERO THERAPEUTICS COM Put 48,300 1,401 n/a n/a n/a
2021-02-16 2020-12-31 13F AKERO THERAPEUTICS COM Put 9,700 250 n/a n/a n/a
2020-11-16 2020-09-30 13F AKERO THERAPEUTICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-14 2020-06-30 13F AKERO THERAPEUTICS Cmn Put 8,500 212 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.